Christina Vessely

Christina Vessely is a highly experienced Principal Consultant at Biologics Consulting, specializing in the development of therapeutic proteins, including peptides, monoclonal antibodies, and vaccines, with a focus on client support from early R&D through commercialization. Previous roles include Director of CMC/Regulatory Affairs at KBI Biopharma, where leadership was provided to a team on regulatory filings, and Associate Director at Merck, overseeing formulation development for therapeutic proteins. Earlier experience encompasses positions as a Formulation Scientist II at Insmed Therapeutic Proteins and a Scientist at FeRx Incorporated, as well as completing a PhD in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus. Christina Vessely holds a B.S. in Chemical Engineering from the Colorado School of Mines.